GSDME promotes MASLD by regulating pyroptosis, Drp1 citrullination-dependent mitochondrial dynamic, and energy balance in intestine and liver

• Published in: Cell death and differentiation 2024-11, Vol.31 (11), p.1467-1486
• Main Authors: Zhu, Jia-Hui, Ouyang, Shen-Xi, Zhang, Guo-Yan, Cao, Qi, Xin, Rujuan, Yin, Hang, Wu, Jing-Wen, Zhang, Yan, Zhang, Zhen, Liu, Yi, Fu, Jiang-Tao, Chen, Yi-Ting, Tong, Jie, Zhang, Jia-Bao, Liu, Jian, Shen, Fu-Ming, Li, Dong-Jie, Wang, Pei
• Format: Article
• Language: English
• Subjects: 13; 13/31; 13/51; 14/1; 14/28; 38/91; 631/337/475; 64/60; 692/699/2743; 82/29; 82/58; Animal models; Apoptosis; Biochemistry; Biomedical and Life Sciences; Body weight; CD163 antigen; Cell Biology; Cell Cycle Analysis; Cell death; Cholesterol; Citrulline; Dynamin; Endoplasmic reticulum; Energy balance; Energy metabolism; Fibrosis; Hepatocytes; Inflammation; Intestine; Leukocytes (neutrophilic); Life Sciences; Liver; Liver diseases; Macrophages; Metabolism; Mitochondria; Mitophagy; Monocytes; Myeloid cells; Nutrient deficiency; Pyroptosis; Stem Cells; Therapeutic targets
• ISSN: 1350-9047; 1476-5403; 1476-5403
• DOI: 10.1038/s41418-024-01343-0

Dysregulated metabolism, cell death, and inflammation contribute to the development of metabolic dysfunction-associated steatohepatitis (MASH). Pyroptosis, a recently identified form of programmed cell death, is closely linked to inflammation. However, the precise role of pyroptosis, particularly gasdermin-E (GSDME), in MASH development remains unknown. In this study, we observed GSDME cleavage and GSDME-associated interleukin-1β (IL-1β)/IL-18 induction in liver tissues of MASH patients and MASH mouse models induced by a choline-deficient high-fat diet (CDHFD) or a high-fat/high-cholesterol diet (HFHC). Compared with wild-type mice, global GSDME knockout mice exhibited reduced liver steatosis, steatohepatitis, fibrosis, endoplasmic reticulum stress, lipotoxicity and mitochondrial dysfunction in CDHFD- or HFHC-induced MASH models. Moreover, GSDME knockout resulted in increased energy expenditure, inhibited intestinal nutrient absorption, and reduced body weight. In the mice with GSDME deficiency, reintroduction of GSDME in myeloid cells—rather than hepatocytes—mimicked the MASH pathologies and metabolic dysfunctions, as well as the changes in the formation of neutrophil extracellular traps and hepatic macrophage/monocyte subclusters. These subclusters included shifts in Tim4 + or CD163 + resident Kupffer cells, Ly6C hi pro-inflammatory monocytes, and Ly6C lo CCR2 lo CX3CR1 hi patrolling monocytes. Integrated analyses of RNA sequencing and quantitative proteomics revealed a significant GSDME-dependent reduction in citrullination at the arginine-114 (R114) site of dynamin-related protein 1 (Drp1) during MASH. Mutation of Drp1 at R114 reduced its stability, impaired its ability to redistribute to mitochondria and regulate mitophagy, and ultimately promoted its degradation under MASH stress. GSDME deficiency reversed the de-citrullination of Drp1 R114 , preserved Drp1 stability, and enhanced mitochondrial function. Our study highlights the role of GSDME in promoting MASH through regulating pyroptosis, Drp1 citrullination-dependent mitochondrial function, and energy balance in the intestine and liver, and suggests that GSDME may be a potential therapeutic target for managing MASH.